Study Maps Somatic Mutations in B Cells of Systemic Lupus Erythematosus Patients, Linking Genetic Changes to Disease Progression
Researchers analyzed somatic mutations across B-cell subsets in 35 systemic lupus erythematosus (SLE) patients and found that double-negative B cells accumulated the highest mutational burden. These mutations were associated with disease duration and immunosuppressive therapy rather than disease activity, and some mutations resembled those found in B-cell lymphomas. The findings suggest that chronic immune stimulation and therapeutic pressure drive clonal evolution in autoimmune disease, potentially explaining disease heterogeneity and progression.
A new study published on bioRxiv examined somatic genome diversification in B cells from 35 systemic lupus erythematosus patients to understand how genetic changes contribute to autoimmune disease. Researchers created a detailed map of somatic mutations across different B-cell subsets and found that double-negative (DN) B cells—a subset implicated in SLE pathology—carried significantly higher mutational burdens than other B-cell populations. Notably, the mutational load correlated with disease duration and exposure to immunosuppressive therapy, but not with current disease activity levels. By integrating single-cell transcriptome data, the team linked these mutations to dysregulated cell signaling and protein quality control pathways. The discovery that DN cells harbored mutations in genes recurrently altered in B-cell lymphomas raises questions about the long-term consequences of chronic autoimmune activation and suggests that therapeutic interventions may inadvertently shape B-cell evolution.
What's missing
The study does not discuss potential clinical implications or whether these somatic mutations could serve as biomarkers for disease progression or treatment response. Additionally, the mechanisms by which immunosuppressive therapy influences mutational patterns, and whether these patterns are reversible or predictive of lymphoma risk in SLE patients, remain open questions acknowledged by the authors.
What different sources said
- bioRxivCenter
Somatic Genome Diversification and Clonal Evolution of Pathogenic B Cells in Systemic Autoimmunity
Related
Study Identifies Microglial Signaling Pathway Linking Stress to Brain Changes
Researchers found that stress activates a microglial signaling pathway (CSF1R) that triggers matrix metalloproteinase activity in the nucleus accumbens, a brain region involved in reward and stress responses. The study used rat models and a CSF1R inhibitor to demonstrate that blocking this pathway reduced stress-induced changes in the brain. This discovery provides insight into the cellular mechanisms by which stress alters brain structure and may inform future treatments for stress-related psychiatric disorders.
Knee Flexion Contracture Alters Neural Control of Ankle Muscles Beyond Mechanical Constraints
A study comparing individuals with chronic knee flexion contracture (KFC) from haemophilia to healthy controls found that KFC produces altered neural activation patterns in ankle plantar flexor muscles during walking. The research used electromyography and coherence analysis to measure muscle activation and neural coordination. The findings suggest that neural adaptations—not just mechanical limitations—drive changes in muscle control during gait in chronic KFC.
Researchers Develop Minimally Invasive Endovascular Neural Interface for Brain Stimulation
Scientists have created a fully endovascular neural implant smaller than 1 cubic millimeter that can be delivered through blood vessels like a stent to stimulate neural circuits. The device uses ultrasound for wireless power and data transmission, and was successfully tested in rabbits to modulate blood pressure through autonomic nervous system stimulation. This technology could enable less invasive alternatives to conventional brain implants for treating neurological and immune disorders.